No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab

INTRODUCTION: Patients with atopic dermatitis (AD) have an increased risk for infections. This open-label extension study, LIBERTY AD OLE, reports the incidence of infections in adults with moderate-to-severe AD treated with dupilumab for up to 4 years. METHODS: We evaluated infections in adults wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, Wollenberg, Andreas, Eichenfield, Lawrence F., Zhang, Haixin, Sierka, Debra, Khokhar, Faisal A., Vakil, Jignesh, Shabbir, Arsalan, Marco, Ainara Rodríguez, Cyr, Sonya L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628338/
https://www.ncbi.nlm.nih.gov/pubmed/36318387
http://dx.doi.org/10.1007/s12325-022-02322-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628338/
https://www.ncbi.nlm.nih.gov/pubmed/36318387
http://dx.doi.org/10.1007/s12325-022-02322-y

Ejemplares similares